There are limited published data on the phenotype of retinitis pigmentosa (RP) related to CNGB1 variants. These data are needed both for prognostic counseling of patients and for understanding potential treatment windows.
R etinitis pigmentosa (RP) is an inherited disorder characterized by a progressive retinal dystrophy with primarily rod photoreceptor dysfunction at presentation. The disorder is highly heterogeneous and affects approximately 1 in 4000 individuals worldwide. [1] [2] [3] [4] Clinically, RP is characterized by night blindness, progressive constriction of peripheral visual fields, and, ultimately, in most patients, reduced visual acuity. The fundus typically shows midperipheral, intraretinal pigment migration associated with retinal pigment epithelium (RPE) atrophy, attenuated retinal vessels, and pallor of the optic nerve head. [4] [5] [6] Approximately 15% to 20% of RP cases are autosomal dominant; 15% are autosomal recessive; 7% are X-linked; 43% are sporadic or simplex cases, most of which are likely to be autosomal recessive; and 15% are unknown. 6, 7 Rarely, RP may be caused by mutations in mitochondrial DNA. 4 Genes associated with RP encode proteins that have a key role in retinal structure and function, including phototransduction or the visual cycle. Some genes are ubiquitously expressed but have a phenotype confined to the eye. 6, 8, 9 Variants in genes encoding the 2 rod cyclic nucleotidegated (CNG) channel subunits have been associated with autosomal recessive RP. 8, 10 The CNG channels are nonselective cation channels localized to the plasma membrane of rod and cone photoreceptors that translate light-mediated changes of second-messenger cyclic guanosine monophosphate into voltage signals. 11, 12 The CNG channels in rods form heterotetramers consisting of 3 α-subunits (CNGA1) and 1 β-subunit (CNGB1), whereas the cone channel is formed by 2 α-subunits (CNGA3) and 2 β-subunits (CNGB3). 13, 14 Variants in CNGB1 are an uncommon cause of RP, accounting for approximately 4% of autosomal recessive RP cases; there are limited reports describing the associated phenotypes. 10, [15] [16] [17] [18] [19] [20] The present report describes the detailed clinical features of 10 affected patients harboring likely pathogenic variants in CNGB1.
Methods

Patients
Ten patients from 9 families were ascertained from the inherited retinal clinics of Moorfields Eye Hospital and Great Ormond Street Hospital for Children. The study was conducted from April 17, 2013, to March 3, 2016 , with final follow-up completed on March 2, 2016. Data were analyzed from October 27, 2014, to March 29, 2016. Informed written consent and peripheral blood samples were obtained for genetic analysis from all participants according to the protocols approved by the Research Management Committees of Moorfields Eye Hospital and Great Ormond Street Hospital for Children, in agreement with the Declaration of Helsinki. 21 There was no financial compensation.
An accurate family history of each patient was recorded, and all underwent a complete ophthalmic examination, which included best-corrected visual acuity, slitlamp biomicroscopy of the anterior segment, and dilated fundus examination. Retinal fundus photographs were obtained by conventional 35°fundus color photographs (Topcon Great Britain Ltd) and in 1 patient by ultra-widefield (up to 200°) confocal laser scanning ophthalmoscopy (Optos plc). Fundus autofluorescence (FAF) imaging (30°and 55°) was performed with a confocal scanning laser ophthalmoscope (HRA+OCT Spectralis; Heidelberg Engineering Ltd). An optically pumped solid-state laser (488 nm) was used for excitation, and a 500-nm barrier filter was used to modulate the reflected light. Spectral-domain optical coherence tomography (OCT) was performed (HRA+OCT Spectralis). Optical coherence tomography imaging was acquired by a broadband 870-nm superluminescent diode that scanned the retina at 40 000 Ascans per second with an optical depth resolution of 7 μm. In particular, the central subfield thickness and integrity of the inner segment ellipsoid (ISe) band of the photoreceptors were assessed in the maculae of both eyes of all patients. Central subfield thickness was measured using an automated viewing module (Spectralis, version 6.3.4.0; Heidelberg Engineering Ltd) with slices visually inspected for segmentation accuracy.
Full-field electroretinography (ERG) (6 patients) and pattern ERG (PERG) ( More than 500 unrelated patients with a range of inherited retinal dystrophies recruited from Moorfields Eye Hospital have undergone this molecular investigation.
Confirmatory bidirectional Sanger sequencing of CNGB1 was performed in all probands and available family members. Amplification of DNA was performed using specifically designed primers by polymerase chain reaction, and the resulting fragments were sequenced using standard protocols.
Variant nomenclature was assigned in accordance with GenBank Accession number NM_001297.4, with nucleotide position 1 corresponding to the A of the ATG initiation codon. Variants were identified as novel if not previously reported in the literature and if absent from dbSNP (http://www.ncbi.nlm.nih .gov/projects/SNP/), EVS, and the Exome Aggregation Consortium database (ExAC; http://exac.broadinstitute.org) containing 61 486 exomes, all accessed on March 21, 2016. Where relevant, potential splice site disruption was assessed using Splice Site Prediction by Neural Network (http://www .fruitfly.org/seq_tools/splice.html).
Results
Clinical Evaluation
The series consisted of 10 patients (7 women). Eight were white British individuals, 1 was Bangladeshi (patient 4), and 1 was Afghani (patient 9). The clinical findings are summarized in the Table, with family pedigrees and identified variants shown in Figure 1 . Mean (SD) age at last review was 47.4 (13.2) years (range, 15-65 years) with a mean follow-up of 3.7 (2.8) years (range, 0-11 years). The initial symptom in all patients was nyctalopia, with onset from infancy to 14 years. No patient reported photophobia. A fine nystagmus was observed in patient 9. Symptomatic peripheral visual field loss occurred later at a mean age of 33.2 (8.0) years (range, 13-40 years), although it was detectable on formal kinetic perimetry in patient 9 at 12 years. Six of 10 patients developed visually significant posterior subcapsular lens opacities in both eyes during follow-up, with subsequent cataract surgery.
Mean Fundus examination of all participants but patient 9 revealed arteriolar attenuation, optic disc pallor, RPE atrophy, and midperipheral intraretinal pigment migration. For patient 9, the youngest participant, narrow retinal vessels and midperipheral RPE mottling were the only observable abnormalities at 18 years ( Figure 2 ). Perifoveal RPE atrophy was additionally present in patients 1, 4, and 10.
Fundus autofluorescence imaging showed a loss of autofluorescence in the midperiphery, with macular or perimacular rings of increased autofluorescence in all patients. Patient 9, with initial preserved autofluorescence, developed a macular ring of increased autofluorescence over a 5-year follow-up period ( Figure 2 ). Three patients (patients 1, 4, and 10) had an additional patchy perifoveal ring of reduced autofluorescence corresponding to their perifoveal RPE atrophy.
One patient (patient 8) with a large paracentral ring of FAF had complete preservation of the ISe band evident on OCT (Figure 2) . In other participants, the lateral extent of the ISe band corresponded to the diameter of the ring of increased signal on FAF, with the most severe loss of the ISe band in patients 1 and 10. In addition, both eyes of patients 3 and 6 and the left eye of patient 7 had an epiretinal membrane; patient 5 had bilateral vitreomacular traction associated with macular edema, and patient 10 had a small, left lamellar macular hole without apparent vitreomacular traction. Interval OCT imaging during a 5-year period in patient 9 demonstrated a marked reduction in the diameter of the ISe band (Figure 2 ). Mean central subfield thickness, excluding patient 5 (macular edema) and patient 9 (information unavailable), was 302. 
CNGB1 Screening
Likely pathogenic variants in CNGB1 were identified in all 9 probands and, after segregation analysis, in a further 3 affected family members, 1 of whom was also available for examination (patient 6). One previously reported variant, c.2957A>T p.
(N986I) in exon 29, was identified in patients 2, 3, 5, 7, and 8 ( Figure 1 ). 16 Four novel variants were detected: 3 nonsense, 
Discussion
This report describes the findings in 10 patients (7 women and 3 men) from 9 families with a typical RP phenotype and likely pathogenic variants in CNGB1. Seven likely pathogenic variants not previously reported in an affected patient were identified. There are limited published data on the CNGB1 retinal phenotype. 10, [15] [16] [17] [18] [19] [20] To our knowledge, only 7 families have been identified with recessive RP due to CNGB1 comprising 3 missense variants, 3 splice site variants, and 1 frameshift variant. Of the 4 families with clinical details, there was a childhood onset of nyctalopia with a later development of peripheral visual field loss reported in 4 patients at 10, 20, and 30 (2 patients) years. 10, 15, 17, 19 Severe loss of visual acuity was present in 3 patients at 24, 57, and 67 years. There were fundus abnormalities typical of RP with midperipheral RPE atrophy and intraretinal bone-spicule pigmentation and variable macular atrophy. Two patients had undetectable rod responses on ERG and severely abnormal cone responses at 24 and 30 years, and 1 patient had undetectable ERG responses at 44 years; PERG was not performed. The patients in the present series had similar features: onset of nyctalopia was seen in childhood with symptomatic visual field loss occurring later, central visual acuity was preserved well into adult life, fundus abnormalities were consistent with RP, and electrophysiologic testing demonstrated a rod-cone dystrophy phenotype. Pattern ERGs showed variable degrees of central or paracentral macular involvement and could be relatively preserved in patients with ERG evidence of severe generalized photoreceptor dysfunction. To our knowledge, this is the first report to describe retinal imaging other than fundus appearance; all patients demonstrated reduced midperipheral autofluorescence, with macular rings of increased autofluorescence corresponding to the size of the remaining ISe band. Abnormal parafoveal rings of increased FAF have been reported in approximately 59% of patients with RP. 27 All patients in the present series demonstrated such abnormal rings; the largest FAF ring surrounded an area that included most of the vascular arcades in a patient (patient 8) with OCT evidence of preserved outer retina ( Figure 2) and relatively preserved PERG (Figure 3 ). The diameter of smaller FAF rings corresponded with the lateral limit of the remaining OCT ISe band, consistent with previous studies of patients with RP that have shown spatial correspondence or correlation between these variables. 28,29 Central subfield thickness was within normal limits. The findings of our study suggest that RP associated with variants in CNGB1 has a good prognosis for central vision despite the early onset of night blindness. The good visual prognosis is reflected by preserved central macular thickness and morphology of the ISe band of the photoreceptors even in adults. A total of 8 different variants in CNGB1 were identified. The previously reported missense variant, p.(N986I), was detected in 5 patients, all British white individuals, suggesting it to be a common CNGB1 variant in this population. 16 p. (N986I) is found in 133 of 120 752 alleles with no homozygotes in the ExAC database (minor allele frequency, 0.0011), including 84 of 66 728 non-Finnish European alleles (minor allele frequency, 0.0013). Patient 1, who was biallelic for nonsense variants, had a more severe phenotype compared with the other patients; the best-corrected visual acuity was 0.3 logMAR (Snellen 20/40) at 47 years, and the visual field was restricted to the central 10°in both eyes. This patient is predicted as being nullizygous for CNGB1 due to nonsense-mediated decay of the transcribed messenger RNA as are patients 4, 9, and 10, suggesting that there is no direct correlation between predicted nullizygous variants and phenotype severity. 30 Of the previously reported patients with clinical details, 2 had splice site variants (c.413-1G>A and c.3444 + 1G>A) and visual loss at 24 and 67 years, respectively; 2 patients with missense variants had preserved central vision into at least their fourth decades. 10, 15, 17, 19 Both splice site variants have been shown in vitro to lead to aberrant splicing and premature termination codons. 19,31 To our 
